Its inhibitory activity against tumor cells was at the nM level in SJSA-1 and RS4;11 cells, and the selectivity for wild-type p53 over mutant or knockout p53 tumor cells was high, without significant toxic side effects [39]. The gene discussed is TP53; the disease is neoplasm.